Search

everythinglearnresearchcommunity

for

Search:↓

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Developing human skin has immune cells with memory-like features.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Different parts of the body have unique immune characteristics in their skin.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

The treatment using a special hydrogel shows promise for promoting hair growth.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.